Crossref
Thyrotropin Suppression for Higher-Risk Thyroid Cancer: What’s the Harm?
Clinical Thyroidology® · 01.07.2026 · 38 (7) · 231-234
DOI: 10.1177/23299711261466483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 13.07.2026. Verfasst von Sana A. Ghaznavi. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ghaznavi, S. A. (2026). Thyrotropin Suppression for Higher-Risk Thyroid Cancer: What’s the Harm?. Clinical Thyroidology®, 38(7), 231-234. https://doi.org/10.1177/23299711261466483
Vancouver
Ghaznavi SA. Thyrotropin Suppression for Higher-Risk Thyroid Cancer: What’s the Harm?. Clinical Thyroidology®. 2026;38(7):231-234. doi:10.1177/23299711261466483
BibTeX
@article{Ghaznavi2026,
author = {Ghaznavi, Sana A.},
title = {Thyrotropin Suppression for Higher-Risk Thyroid Cancer: What’s the Harm?},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {7},
pages = {231--234},
doi = {10.1177/23299711261466483}
}
EUVIMED